OKYO Pharma CDO Gary S. Jacob Receives 3,500-Share Award

What Happened
Gary S. Jacob, Chief Development Officer and a director of OKYO Pharma Ltd (OKYO), received an award/acquisition of 3,500 shares on July 21, 2026. The transaction is reported as 3,500 shares at $1.40 per share for a total reported value of $4,900. This was a grant/award (code A) — an issuance of shares rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-21; Filing date (accession): 2026-07-23 (Form 4 filed timely).
• Transaction type/code: Award/Grant (A).
• Shares received: 3,500; Price per share: $1.40; Total value: $4,900.
• Shares owned after transaction: Not specified in the details provided.
• Footnotes/plan notes: No 10b5-1 plan, tax-withholding, or other special footnotes indicated in the supplied transaction information.

Context
Grants/awards are typically compensation-related and do not necessarily indicate immediate buying or selling sentiment. The dollar value here is modest (~$4.9k), so while it’s an insider acquisition of company stock, it’s a routine compensation event rather than a large personal investment signal.